Shield Therapeutics (LSE:STX) Change In Inventory : £-1.02 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics Change In Inventory?

Shield Therapeutics's change in inventory for the quarter that ended in Jun. 2023 was £-0.94 Mil. It means Shield Therapeutics's inventory increased by £0.94 Mil from Dec. 2022 to Jun. 2023 .

Shield Therapeutics's change in inventory for the fiscal year that ended in Dec. 2022 was £0.18 Mil. It means Shield Therapeutics's inventory declined by £0.18 Mil from Dec. 2021 to Dec. 2022 .

Shield Therapeutics's Total Inventories for the quarter that ended in Jun. 2023 was £2.70 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shield Therapeutics's Days Inventory for the quarter that ended in Jun. 2023 was 181.71.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shield Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 was 1.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shield Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.48.

Shield Therapeutics Change In Inventory Historical Data

The historical data trend for Shield Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shield Therapeutics Change In Inventory Chart

Shield Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

0.02

-0.84

-0.43

-0.26

0.18

Shield Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial													-0.06	-0.20	0.26	-0.08	-0.94

Shield Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-1.02 Mil.

Shield Therapeutics (LSE:STX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shield Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2.076	/	2.085	*	365 / 2
	=	181.71

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shield Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.085	/	2.076
	=	1.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shield Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.076	/	4.334
	=	0.48

Shield Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (LSE:STX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SHIEF:USA 1JS:Germany

Address

Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF

Website

https://www.shieldtherapeutics.com

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.